Palleon Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.The company's biotechnology platform integrates technologies and insights from scientific leaders all over the world in the fields of glycoscience and human immunology to create a novel approach to treating cancer by targeting multiple immune cell types, providing physicians with a wider range of rational combination therapies to treat cancer and tackle resistance to first-generation immuno-oncology agents.
Palleon Pharmaceuticals has raised $100M across 1 funding round on record, the most recent an undisclosed round of $100M announced in Sep 2020.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Palleon Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Palleon Pharmaceuticals Funding Rounds
Palleon Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Palleon Pharmaceuticals Funding Compared to Other Biotechnology Startups
Palleon Pharmaceuticals' latest round of $100M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Palleon Pharmaceuticals in Biotechnology and Waltham
Companies Similar to Palleon Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Palleon Pharmaceuticals Funding FAQs
What does Palleon Pharmaceuticals do?
Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.The company's biotechnology platform integrates technologies and insights from scientific leaders all over the world in the fields of glycoscience and human immunology to create a novel approach to treating cancer by targeting multiple immune cell types, providing physicians with a wider range of rational combination therapies to treat cancer and tackle resistance to first-generation immuno-oncology agents.
How much funding has Palleon Pharmaceuticals raised?
Palleon Pharmaceuticals has raised $100M across 1 round on record. The most recent is an undisclosed round of $100M announced in Sep 2020.
When did Palleon Pharmaceuticals last raise funding?
Palleon Pharmaceuticals' most recent funding round on record is an undisclosed round of $100M, announced in Sep 2020.
Who is the CEO of Palleon Pharmaceuticals?
Jim Broderick is listed as CEO at Palleon Pharmaceuticals.
Where is Palleon Pharmaceuticals headquartered?
Palleon Pharmaceuticals is based in Waltham, Massachusetts, United States.
How many employees does Palleon Pharmaceuticals have?
Palleon Pharmaceuticals is in the 11-50 employee band.
How does Palleon Pharmaceuticals' funding compare to other Biotechnology startups?
Palleon Pharmaceuticals' latest round of $100M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Palleon Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Palleon Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.